These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7606858)

  • 1. European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL.
    Clin Exp Immunol; 1995 Jul; 101 Suppl 1(Suppl 1):29-34. PubMed ID: 7606858
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 4. Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials.
    Tesar V; Ríhová Z; Jancová E; Rysavá R; Merta M;
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v2-4. PubMed ID: 12817056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
    Jayne DR; Rasmussen N
    Mayo Clin Proc; 1997 Aug; 72(8):737-47. PubMed ID: 9276602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
    Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
    Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing.
    Ecklund SR; Saluta GS; Agudelo CA; Pisko EJ
    South Med J; 1992 Feb; 85(2):132-8. PubMed ID: 1738878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of ANCA-associated systemic vasculitis.
    Salama AD
    J R Soc Med; 1999 Sep; 92(9):456-61. PubMed ID: 10645294
    [No Abstract]   [Full Text] [Related]  

  • 11. Antineutrophilic cytoplasmic antibodies (ANCA) and vasculitis.
    Staud R; Williams RC
    Compr Ther; 1994; 20(11):623-7. PubMed ID: 7851093
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and therapy in systemic vasculitis with renal involvement].
    Andrassy K; Ritz E
    Ther Umsch; 1994 Dec; 51(12):813-8. PubMed ID: 7784994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
    Eisenberger U; Hess C
    Ther Umsch; 2008 May; 65(5):295-301. PubMed ID: 18622935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
    Jordan SC; Toyoda M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of autoimmune responses in systemic vasculitis.
    Lockwood CM; Ronda N
    Ann Ital Med Int; 1992; 7(4):203-8. PubMed ID: 1338488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
    Hellmich B; Flossmann O; Gross WL; Bacon P; Cohen-Tervaert JW; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott DG; Witter J; Yazici H; Luqmani RA
    Ann Rheum Dis; 2007 May; 66(5):605-17. PubMed ID: 17170053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of systemic vasculitis.
    Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
    J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
    Arnold DF; Timms A; Luqmani R; Misbah SA
    J Clin Pathol; 2010 Aug; 63(8):678-80. PubMed ID: 20702467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Autoimmune Vasculitis - Advances in Pathogenesis and Therapies.
    Ooi JD; Deng J; De Souza AWS
    Front Immunol; 2021; 12():720257. PubMed ID: 34220872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.